MARIA TERESA
COIRAS LOPEZ
PROFESOR TITULAR
![Foto de José Valentin](/img/nophoto.png)
José Valentin
García Gutiérrez
Publicaciones en las que colabora con José Valentin García Gutiérrez (13)
2023
-
Persistent Immunity against SARS-CoV-2 in Individuals with Oncohematological Diseases Who Underwent Autologous or Allogeneic Stem Cell Transplantation after Vaccination
Cancers, Vol. 15, Núm. 8
-
Regular Humoral and Cellular Immune Responses in Individuals with Chronic Myeloid Leukemia Who Received a Full Vaccination Schedule against COVID-19
Cancers, Vol. 15, Núm. 20
-
Sustained Cytotoxic Response of Peripheral Blood Mononuclear Cells from Unvaccinated Individuals Admitted to the ICU Due to Critical COVID-19 Is Essential to Avoid a Fatal Outcome
International Journal of Environmental Research and Public Health, Vol. 20, Núm. 3
2022
-
Association between HLA-C alleles and COVID-19 severity in a pilot study with a Spanish Mediterranean Caucasian cohort
PLoS ONE, Vol. 17, Núm. 8 August
-
Early Cellular and Humoral Responses Developed in Oncohematological Patients after Vaccination with One Dose against COVID-19
Journal of Clinical Medicine, Vol. 11, Núm. 10
-
Strong Cellular Immune Response, but Not Humoral, against SARS-CoV-2 in Oncohematological Patients with Autologous Stem Cell Transplantation after Natural Infection
Journal of Clinical Medicine, Vol. 11, Núm. 8
-
Strong Humoral but Not Cellular Immune Responses against SARS-CoV-2 in Individuals with Oncohematological Disease Who Were Treated with Rituximab before Receiving a Vaccine Booster
Cancers, Vol. 14, Núm. 22
2021
-
Identification of immunological parameters as predictive biomarkers of relapse in patients with chronic myeloid leukemia on treatment-free remission
Journal of Clinical Medicine, Vol. 10, Núm. 1, pp. 1-21
-
Impaired Antibody-Dependent Cellular Cytotoxicity in a Spanish Cohort of Patients With COVID-19 Admitted to the ICU
Frontiers in Immunology, Vol. 12
-
Impaired Cytotoxic Response in PBMCs From Patients With COVID-19 Admitted to the ICU: Biomarkers to Predict Disease Severity
Frontiers in Immunology, Vol. 12
-
Provirus reactivation is impaired in HIV-1 infected individuals on treatment with dasatinib and antiretroviral therapy
Biochemical Pharmacology, Vol. 192
2020
-
Cytotoxic cell populations developed during treatment with tyrosine kinase inhibitors protect autologous CD4+ T cells from HIV-1 infection
Biochemical Pharmacology, Vol. 182
2018
-
Evaluation of resistance to HIV-1 infection ex vivo of PBMCs isolated from patients with chronic myeloid leukemia treated with different tyrosine kinase inhibitors
Biochemical Pharmacology, Vol. 156, pp. 248-264